XOMA (NASDAQ:XOMAP – Get Free Report) is anticipated to post its resultson Thursday, July 30th. Analysts expect XOMA to announce earnings of $0.1761 per share and revenue of $13.91 million for the quarter.
XOMA Price Performance
NASDAQ XOMAP opened at $24.98 on Thursday. The business’s fifty day moving average price is $25.30 and its 200-day moving average price is $25.81. XOMA has a 1-year low of $24.93 and a 1-year high of $30.00.
XOMA Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, July 14th. Investors of record on Thursday, July 2nd were given a dividend of $0.5391 per share. This represents a $2.16 dividend on an annualized basis and a yield of 8.6%. The ex-dividend date was Thursday, July 2nd.
About XOMA
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Read More
- Five stocks we like better than XOMA
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
